Association between Source of Infection and Hospital Mortality in Patients Who Have Septic Shock

被引:213
作者
Leligdowicz, Aleksandra [1 ]
Dodek, Peter M. [3 ,4 ,5 ]
Norena, Monica [4 ,5 ]
Wong, Hubert [2 ,4 ,5 ]
Kumar, Aseem [6 ]
Kumar, Anand [7 ]
机构
[1] Univ British Columbia, Dept Internal Med, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada
[3] St Pauls Hosp, Div Crit Care Med, Vancouver, BC V6Z 1Y6, Canada
[4] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada
[5] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[6] Laurentian Univ, Dept Chem & Biochem, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada
[7] Univ Manitoba, Hlth Sci Ctr, St Boniface Hosp, Sect Crit Care Med, Winnipeg, MB, Canada
关键词
septic shock; pathogenesis; hospital mortality; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; ACTIVATED PROTEIN-C; SEVERE SEPSIS; ANTIMICROBIAL THERAPY; SEVERITY; SURVIVAL; ADULTS; IMMUNOSUPPRESSION; NOREPINEPHRINE;
D O I
10.1164/rccm.201310-1875OC
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Rationale: Mortality caused by septic shock may be determined by a systemic inflammatory response, independent of the inciting infection, but it may also be influenced by the anatomic source of infection. Objectives: To determine the association between the anatomic source of infection and hospital mortality in critically ill patients who have septic shock. Methods: This was a retrospective, multicenter cohort study of 7,974 patients who had septic shock in 29 academic and community intensive care units in Canada, the United States, and Saudi Arabia from January 1989 to May 2008. Measurements and Main Results: Subjects were assigned 1 of 20 anatomic sources of infection based on clinical diagnosis and/or isolation of pathogens. The primary outcome was hospital mortality. Overall crude hospital mortality was 52% (21-85% across sources of infection). Variation in mortality remained after adjusting for year of admission, geographic source of admission, age, sex, comorbidities, community- versus hospital-acquired infection, and organism type., The source of infection with the highest standardized hospital mortality was ischemic bowel (75%); the lowest was obstructive uropathy associated urinary tract infection (26%). Residual variation in adjusted hospital mortality was not explained by Acute Physiology and Chronic Health Evaluation II score, number of Day 1 organ failures, bacteremia, appropriateness of empiric antimicrobials, or adjunct therapies. Inpatients who received appropriate antimicrobials after onset of hypotension, source of infection was associated with death after adjustment for both predisposing and downstream factors. Conclusions: Anatomic source of infection should be considered in future trial designs and analyses, and in development of prognostic scoring systems.
引用
收藏
页码:1204 / 1213
页数:10
相关论文
共 55 条
[1]
Epidemiology and economic evaluation of severe sepsis in France:: age, severity, infection site, and place if acquisition (community, hospital, or intensive care unit) as determinants of workload and cost [J].
Adrie, C ;
Alberti, C ;
Chaix-Couturier, C ;
Azoulay, E ;
de Lassence, A ;
Cohen, Y ;
Meshaka, P ;
Cheval, C ;
Thuong, M ;
Troché, G ;
Garrouste-Orgeas, M ;
Timsit, JF .
JOURNAL OF CRITICAL CARE, 2005, 20 (01) :46-58
[2]
The Search for Effective Therapy for Sepsis Back to the Drawing Board? [J].
Angus, Derek C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (23) :2614-2615
[3]
The Lingering Consequences of Sepsis A Hidden Public Health Disaster? [J].
Angus, Derek C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (16) :1833-1834
[4]
Septic shock [J].
Annane, D ;
Bellissant, E ;
Cavaillon, JM .
LANCET, 2005, 365 (9453) :63-78
[5]
Recombinant Human Activated Protein C for Adults with Septic Shock A Randomized Controlled Trial [J].
Annane, Djillali ;
Timsit, Jean-Francois ;
Megarbane, Bruno ;
Martin, Claude ;
Misset, Benoit ;
Mourvillier, Bruno ;
Siami, Shidasp ;
Chagnon, Jean-Luc ;
Constantin, Jean-Michel ;
Petitpas, Franck ;
Souweine, Bertrand ;
Amathieu, Roland ;
Forceville, Xavier ;
Charpentier, Claire ;
Tesniere, Antoine ;
Chastre, Jean ;
Bohe, Julien ;
Colin, Gwenhael ;
Cariou, Alain ;
Renault, Alain ;
Brun-Buisson, Christian ;
Bellissant, Eric .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (10) :1091-1097
[6]
ARISE, 2007, Crit Care Resusc, V9, P8
[7]
Bundled care for septic shock: An analysis of clinical trials [J].
Barochia, Amisha V. ;
Cui, Xizhong ;
Vitberg, David ;
Suffredini, Anthony F. ;
O'Grady, Naomi P. ;
Banks, Steven M. ;
Minneci, Peter ;
Kern, Steven J. ;
Danner, Robert L. ;
Natanson, Charles ;
Eichacker, Peter Q. .
CRITICAL CARE MEDICINE, 2010, 38 (02) :668-678
[8]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[9]
Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study [J].
Blanco, Jesus ;
Muriel-Bombin, Arturo ;
Sagredo, Victor ;
Taboada, Francisco ;
Gandia, Francisco ;
Tamayo, Luis ;
Collado, Javier ;
Garcia-Labattut, Angel ;
Carriedo, Demetrio ;
Valledor, Manuel ;
De Frutos, Martin ;
Lopez, Maria-Jesus ;
Caballero, Ana ;
Guerra, Jose ;
Alvarez, Braulio ;
Mayo, Agustin ;
Villar, Jesus .
CRITICAL CARE, 2008, 12 (06)
[10]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655